Differences in Alimentary Glucose Absorption and Intestinal Disposal of Blood Glucose After Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy.

@article{Cavin2016DifferencesIA,
  title={Differences in Alimentary Glucose Absorption and Intestinal Disposal of Blood Glucose After Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy.},
  author={Jean-Baptiste Cavin and Anne Couvelard and Rachida Lebtahi and Robert Ducroc and Konstantinos Arapis and Eglantine Voitellier and Françoise Cluzeaud and Laura Gillard and Muriel Hourseau and Nidaa Mikail and Lara Ribeiro-Parenti and Nathalie Kapel and Jean Pierre Marmuse and Andr{\'e} Bado and Maude le Gall},
  journal={Gastroenterology},
  year={2016},
  volume={150 2},
  pages={
          454-64.e9
        }
}
BACKGROUND & AIMS Bariatric procedures, such as Roux-en-Y gastric bypass (RYGB) or vertical sleeve gastrectomy (VSG), are the most effective approaches to resolve type 2 diabetes in obese individuals. Alimentary glucose absorption and intestinal disposal of blood glucose have not been directly compared between individuals or animals that underwent RYGB vs VSG. We evaluated in rats and humans how the gut epithelium adapts after surgery and the consequences on alimentary glucose absorption and… 

Figures from this paper

Serum glucose excretion after Roux-en-Y gastric bypass: a potential target for diabetes treatment
TLDR
A novel, potentially targetable glucose homeostatic mechanism in the small intestine is suggested after bariatric surgery or AREG administration induces apical and basolateral membrane GLUT1 expression in theSmall intestinal enterocytes, resulting in increased serum glucose excretion in the gut lumen.
Postprandial Nutrient Handling and Gastrointestinal Hormone Secretion After Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy.
TLDR
RYGB was characterized by accelerated absorption of glucose and amino acids, whereas protein metabolism after SG did not differ significantly from controls, suggesting that different mechanisms explain improved glycemic control and weight loss after these surgical procedures.
Intestinal Glucose Absorption Was Reduced by Vertical Sleeve Gastrectomy via Decreased Gastric Leptin Secretion
TLDR
It is demonstrated that the decreased secretion of gastric leptin in VSG results in a decrease in intestinal glucose absorption via modulation of GLUT2 translocation.
Malabsorption and intestinal adaptation after one anastomosis gastric bypass compared with Roux-en-Y gastric bypass in rats.
TLDR
In rats, MGB led to greater protein malabsorption and energy loss than RYGB, which was not compensated by intestinal overgrowth and increased expression of peptide transporters in the jejunum.
Small intestinal metabolism is central to whole-body insulin resistance
TLDR
Proximal gut plays a crucial role in controlling insulin sensitivity through a distinctive metabolic signature involving hepatic gluconeogenesis and muscle insulin resistance, and bypassing the jejunum is beneficial in terms of insulin-mediated glucose disposal in obesity.
Portal milieu and the interplay of multiple antidiabetic effects after gastric bypass surgery.
TLDR
Portal milieu after gastric bypass surgery is an underinvestigated area and changes in intestinal function and subsequent changes in portal venous milieu drive some of these postoperative benefits, which raises the hope of less invasive alternatives.
Additional effects of duodenojejunal bypass on glucose metabolism in a rat model of sleeve gastrectomy
TLDR
The additional effects of duodenojejunal bypass on glucose metabolism after SG may be related to increased expression of GLUT1 and SGLT1 in the AL.
Altered Glucose Metabolism and Glucose Transporters in Systemic Organs After Bariatric Surgery
TLDR
Evaluated changes in continuous dynamic FDG uptake patterns after RYGB and the correlation between glucose metabolism and its transporters in variable endocrine organs using 18F-fluoro-2-deoxyglucose positron emission tomography images suggest that the newly developed glucose biodistribution accompanied by increased glucose transporter is a mechanism associated with the systemic effect of RY GB.
Understanding intestinal glucose transporter expression in obese compared to non-obese subjects
TLDR
The absence of GLut-1 expression in both the obese and non-obese groups is consistent with the established view of GLUT-1 being abundantly present in fetal intestine but diminished to negligible levels by adulthood.
...
...

References

SHOWING 1-10 OF 38 REFERENCES
Impact of Roux-en-Y gastric bypass surgery on rat intestinal glucose transport.
TLDR
It is shown duodenal exclusion significantly influences both intestinal structure and glucose transport function, with glucose absorptive capacity reduced after RYGB, providing a novel mechanistic explanation for some of the antidiabetic effects of RyGB.
Weight-independent changes in blood glucose homeostasis after gastric bypass or vertical sleeve gastrectomy in rats.
TLDR
In obese rats, VSG is as effective as RYGB for increasing secretion of GLP-1 and insulin and improving hepatic sensitivity to insulin; these effects are independent of weight loss.
Reprogramming of Intestinal Glucose Metabolism and Glycemic Control in Rats After Gastric Bypass
TLDR
It is demonstrated by positron emission tomography–computed tomography scanning and biodistribution analysis using 2-deoxy-2-[18F]fluoro-d-glucose that reprogramming of intestinal glucose metabolism renders the intestine a major tissue for glucose disposal, contributing to the improvement in glycemic control after RYGB.
Regulation of gastric emptying rate and its role in nutrient-induced GLP-1 secretion in rats after vertical sleeve gastrectomy.
TLDR
Findings demonstrate greatly accelerated gastric emptying in rat models of RYGB and VSG this is likely due to increased gastric pressure and reduced responses to inhibitory feedback from the intestine, and direct infusion of liquid nutrients into the duodenum caused significantly greater GLP-1 release in VSG compared with shams.
Intestinal sweet-sensing pathways and metabolic changes after Roux-en-Y gastric bypass surgery.
TLDR
Failure of BP limb exposure to saccharin to increase Roux limb glucose uptake suggests that isolation of T1R2/3 is unlikely to be involved in metabolic benefits of RYGB, as restimulation failed to reverse changes in intestinal glucose absorption capacity.
Sleeve Gastrectomy Does Not Cause Hypertrophy and Reprogramming of Intestinal Glucose Metabolism in Rats
TLDR
Adaptive hypertrophy and reprogramming of glucose metabolism in the small intestine are not necessary for VSG to improve body composition and glycemic control.
Remodeling of the Residual Gastric Mucosa after Roux-En-Y Gastric Bypass or Vertical Sleeve Gastrectomy in Diet-Induced Obese Rats
TLDR
A hyperplasia of the mucous neck cells, a transit cell population of the stomach bearing differentiating capacities into zymogenic and peptic cells is demonstrated for the first time in rats after Roux-en-Y gastric bypass and vertical sleeve gastrectomy.
Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes
TLDR
Numerous alterations in the distribution of enteroendocrine cells and their expression of hormonal genes are seen after RYGB and include increased density of GLP-1, PYY, CCK, GIP- and PC2-positive cells, reduced gene expression of GHRL, SCT and GIP and increased expression of GCG.
...
...